Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1375367Generated: October 29, 2026

tert-butyl 3-({1-[2-(benzyloxy)-2-oxoethyl]-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl}methyl)-1H-indazole-1-carboxylate → (3-{[1-(tert-butoxycarbonyl)-1H-indazol-3-yl]methyl}-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-1-yl)acetic acid

https://huagongshe.com/reaction/1375367

Reaction equation

Participants

RoleNameHCIDCharge
Reactanttert-butyl 3-({1-[2-(benzyloxy)-2-oxoethyl]-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl}methyl)-1H-indazole-1-carboxylateHCID 69426247—
CatalystPalladiumHCID 23938—
SolventEthyl AcetateHCID 8857—
Product(3-{[1-(tert-butoxycarbonyl)-1H-indazol-3-yl]methyl}-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-1-yl)acetic acidHCID 6942382885.6%

Reaction Steps

(0.3 g, 0.95 mM) of tert-butyl 3-({1-[2-(benzyloxy)-2-oxoethyl]-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3-yl}methyl)-1H-indazole-1-carboxylate were dissolved in 10 ml of ethyl acetate and 50 mg of 10% Pd/C were added. Reaction mixture was hydrogenated at atm. Pressure overnight. Catalyst was removed by filtration and was solvent evaporated under reduced pressure. 0.22 g of product was obtained.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07169773B2
Source datasetuspto-grants-2007_01
ORD IDord-270f55e9f13f46a4b95459fdd24cbd6b
Source noteuspto-grants-2007_01